TP53 and neoplasm: Silencing COP1 expression in hepatocellular carcinoma (HCC) cells and in mouse xenograft models using HCC cells inhibits cell proliferation and tumor growth, respectively, in a p53-dependent manner, highlighting COP1 as a potential therapeutic target [185].